Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostatic transitional cell carcinoma: pathologic features and clinical management.

Steven S Shen1, Seth P Lerner

  • 1Department of Pathology, The Methodist Hospital and Weill Medical College of Cornell University, 6565 Fannin Street, Houston, TX 77030, USA. stevenshen@tmh.tmc.edu

Expert Review of Anticancer Therapy
|November 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T<sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer.

Science immunology·2026
Same author

Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4<sup>+</sup>CD8<sup>+</sup> T cells.

Cell reports. Medicine·2026
Same author

Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder Cancer.

European urology open science·2026
Same author

Radiogenomic analysis of muscle-invasive bladder cancer using CT-based texture analysis.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

Narrative Review of Potential Non-Surgical Treatments for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer.

Journal of clinical medicine·2026
Same author

Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression.

Cancer letters·2026
Same journal

Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.

Expert review of anticancer therapy·2026
Same journal

Barriers to the use of brachytherapy for treatment of cervical cancer and prostate cancer in low- and middle-income countries.

Expert review of anticancer therapy·2026
Same journal

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

Expert review of anticancer therapy·2026
Same journal

Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategies.

Expert review of anticancer therapy·2026
Same journal

RTsDEN: reverse task attention enabled deep learning model for lung cancer detection using computed tomography.

Expert review of anticancer therapy·2026
Same journal

The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinoma.

Expert review of anticancer therapy·2026
See all related articles

Prostatic transitional cell carcinoma (pTCC) is common in bladder cancer patients, especially with high-grade tumors. This review clarifies pTCC patterns, clinical significance, and management strategies for better patient care.

Area of Science:

  • Urooncology
  • Surgical Pathology
  • Cancer Biology

Background:

  • Prostatic involvement by transitional cell carcinoma (pTCC) is frequently observed in bladder cancer patients.
  • High-grade invasive tumors and urothelial carcinoma in situ are associated with a higher incidence of pTCC.
  • The clinical significance and management of pTCC remain areas of ongoing investigation.

Purpose of the Study:

  • To review the current understanding of pTCC biology and histological patterns.
  • To discuss the clinical significance and management options for pTCC.
  • To propose a rational approach for managing pTCC in bladder cancer patients.

Main Methods:

  • Literature review of pTCC in bladder cancer.
  • Analysis of histological patterns and clinical significance.

Related Experiment Videos

  • Evaluation of management strategies and diagnostic modalities.

    • Main Results:

    • Various patterns and levels of prostatic involvement by TCC have been described.
    • The impact of pTCC on patient management and prognosis is recognized.
    • The roles of prostatic urethral biopsy and intraoperative frozen section are not universally defined.

    Conclusions:

    • A comprehensive understanding of pTCC biology and histology is crucial.
    • Management strategies should be tailored to the individual patient's tumor stage and characteristics.
    • Further research is needed to standardize diagnostic and therapeutic approaches for pTCC.